Skip to main content
SpringerLink
Log in

Stem Cell Banking

  • Book
  • © 2014

Overview

Editors:
  1. Dusko Ilic

    1. Division of Women's Health, King's College London School of Medicine, United Kingdom

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Explores the current status and future prospects of stem cell banking
  • Examines all aspects of stem cell banking from type of bank and type of stem cells, regulatory landscape, public versus private, and other funding components
  • Highlights stem cell banking industry in new markets such as Brazil, Russia, India, and China
  • Includes supplementary material: sn.pub/extras

Part of the book series: Stem Cell Biology and Regenerative Medicine (STEMCELL)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (14 chapters)

  1. Front Matter

    Pages i-xvii
    Download chapter PDF

  3. Stem Cell Banking Worldwide

    1. Front Matter

      Pages 65-65
      Download chapter PDF

    2. Donor Recruitment and Eligibility Criteria for HLA-Homozygous iPS Cell Bank in Japan

      • Megumu K. Saito, Ayumi Matsunaga, Naoko Takasu, Shinya Yamanaka
      Pages 67-76

    3. Banking of Pluripotent Stem Cells: Issues and Opportunities from the NIH Perspective

      • Anastasia G. Efthymiou, Mahendra Rao, Justin Lowenthal
      Pages 77-93

    4. Sibling Donor Cord Blood Program: Children’s Hospital Research Center Oakland and Beyond

      • Nahal Rose Lalefar, Bertram Lubin
      Pages 95-102

    5. Anthony Nolan Experience: Issues and Strategy for Cord Blood Banking from Ethnic Minority Groups

      • Fatma Hatimy, Monica Del Olmo, Linda Moss, Velibor Milovanovic, Sergio Querol, Alejandro J. Madrigal et al.
      Pages 103-109

    6. Establishment of Mesenchymal Stem Cell Banks in India

      • Chandra Viswanathan, Prathibha Shetty
      Pages 111-122

    7. Stem Cell Banking in Iran

      • Newsha Haghparast, Mohammad Pakzad, Parvaneh Farzaneh, Marzieh Ebrahimi, Vahid Hajihosseini, Mahdi Tondar et al.
      Pages 123-141

    8. Stem Cell Biobanks and Long-Term Sustainability: A Swiss Working Model

      • Silvana Bardelli, Tiziano Moccetti
      Pages 143-153

    9. Establishing a Public Cord Blood Bank and Regulatory Framework in Parallel: A Serbian Example

      • Dragana Vujic, Emilija Lazic, Zeljko Zecevic, Svetlana Vekic
      Pages 155-163

  4. Back Matter

    Pages 165-168
    Download chapter PDF
Back to top

Keywords

About this book

This book exemplifies experience across the globe in banking of cord blood, mesenchymal, embryonic and induced pluripotent stem cells for clinical use from the United States, Canada, the European Union, Switzerland and Japan to Iran, India and Serbia. The concerns are similar regardless of stem cell type or origin. Implementing core values and common standards depend often on specific circumstances of political and economic setting, which makes flexibility as important as systematic planning. Banking of stem cells is not just building a repository and storing samples. The planning, design, construction and maintenance involve multiple skilled professionals. Stem cell banks are points where technology and medicine converge with ethics, laws and regulations. If properly designed and organized, their utilization will have a broad impact not only on the scientific community and medical professionals but also on the general public.

Editors and Affiliations

  • Division of Women's Health, King's College London School of Medicine, United Kingdom

    Dusko Ilic

About the editor

Dr. Dusko Ilic obtained his MD degree and BSci in Molecular Biology at the University of Belgrade, his PhD at the Tokyo University, Japan and he completed postdoctoral training at the University of California in San Francisco. Before joining King’s College School of Medicine in London, he held positions of Adjunct Associate Professor at the University of California San Francisco, Consultant at the Veteran Affairs Medical Center, San Francisco and as Director of R&D at StemLifeLine, a California-licensed stem cell company. Dr. Ilic's current research interests are human embryonic stem (hES) cells, induced pluripotent stem (iPS) cells, and mesenchymal stem cells and their potential in drug discovery and cell-based therapies.

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation